AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.070
+0.010 (0.94%)
At close: Mar 9, 2026, 4:00 PM EDT
1.030
-0.040 (-3.74%)
After-hours: Mar 9, 2026, 4:19 PM EDT
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
27.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 2.52M | -839.00K | -24.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kyntra Bio | 8.30M |
| Evaxion | 7.53M |
| Cue Biopharma | 7.10M |
| Dyadic International | 3.34M |
| IGC Pharma | 1.11M |
| Exicure | 500.00K |
| Hyperion DeFi | 345.32K |
AEON News
- 6 weeks ago - AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - GlobeNewsWire
- 2 months ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 3 months ago - AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - GlobeNewsWire
- 3 months ago - AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - GlobeNewsWire
- 4 months ago - AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth - GlobeNewsWire
- 4 months ago - AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes - GlobeNewsWire
- 5 months ago - AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 - GlobeNewsWire
- 7 months ago - AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire